A Phase 1b Study to Evaluate the Safety, Tolerability and Drug-Drug Interactions of ANX005 and Intravenous Immunoglobulin (IVIg) in Subjects with Guillain-Barre Syndrome

Project: Research project

Description

A Phase 1b Study to Evaluate the Safety, Tolerability and Drug-Drug Interactions of ANX005 and Intravenous Immunoglobulin (IVIg) in Subjects with Guillain-Barre Syndrome
StatusActive
Effective start/end date10/1/199/30/22

Funding

  • ANNEXON, INC

Fingerprint

Guillain-Barre Syndrome
Intravenous Immunoglobulins
Drug Interactions
Safety
Pharmaceutical Preparations